NEW! SARS-CoV-2 PepMix™ Peptide Pools & Microarrays

The current COVID-19 outbreak generates an urgent demand for SARS-CoV-2 related peptide products enabling definition of immune-relevant antigens and identification of B- and T-cell epitopes, development of immune-therapeutic strategies and tools for antigen specific immune monitoring.

In response, JPT has accelerated development of a broad collection of SARS-CoV-2 PepMix™ Peptide Pools* spanning the most relevant antigens to address cellular immunity including but not limited to the Spike, Nucleo, Envelope and Membrane Proteins.

In addition, we developed a Pan-Coronavirus RepliTope™ Peptide Microarray spanning the entire SARS-CoV-2 proteome and selected antigens of MERS-CoV, Common Cold Coronaviruses (HCoV-229e, HCoV-OC43), and SARS-CoV for profiling humoral immune responses.

As the products are still in manufacturing they will become available in approx. 3 weeks, but you can already order through our shop or request a quote.

In an effort to manage capacities, we highly appreciate your feedback on your anticipated needs for larger amounts, higher purities and clinical grade products.

As always, we encourage your feedback and questions!

*Please note: As time is critical we want to provide these tools to researchers as fast as possible. Hence, we will initially release Coronavirus PepMixesTM of slightly lower specification compared to our fully purified standard PepMixes™. Notwithstanding the above, our Coronavirus PepMixes™ only contain peptides that are fully quality controlled for identity and purity allowing research and discovery studies. We continue working with highest priority on the provision of fully purified PepMixes™ and will inform you as soon as they are available.

Stay in touch and be the first to receive the latest news!